q3 adjusted earnings per share $2.74.
q3 revenue $4.9 billion versus refinitiv ibes estimate of $4.51 billion.
expects fy 2021 revenues to grow about 16.5% to 17.0% on a reported basis, an increase from the prior guidance of 12% to 14%.
expects fiscal year 2021 currency-neutral revenue growth of about 14.0% versus its prior guidance of 10% to 12%.
expects fy 2021 adjusted diluted earnings per share to be between $12.85 and $12.95, an increase from the prior guidance of between $12.75 and $12.85.
bd- in recent weeks co saw impact on elective procedures from covid delta variant in some u.s. states & assumes some continuation of this in outlook.
